These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 24327452

  • 21. Relationship between ecstasy use and depression: a study controlling for poly-drug use.
    Roiser JP, Sahakian BJ.
    Psychopharmacology (Berl); 2004 May; 173(3-4):411-7. PubMed ID: 14652710
    [Abstract] [Full Text] [Related]

  • 22. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 23. One-year outcomes of prenatal exposure to MDMA and other recreational drugs.
    Singer LT, Moore DG, Min MO, Goodwin J, Turner JJ, Fulton S, Parrott AC.
    Pediatrics; 2012 Sep; 130(3):407-13. PubMed ID: 22908109
    [Abstract] [Full Text] [Related]

  • 24. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K, Parrott A, Turner J.
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [Abstract] [Full Text] [Related]

  • 25. Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.
    MacInnes N, Handley SL, Harding GF.
    J Psychopharmacol; 2001 Sep; 15(3):181-6. PubMed ID: 11565625
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.
    Moore DG, Turner JD, Parrott AC, Goodwin JE, Fulton SE, Min MO, Fox HC, Braddick FM, Axelsson EL, Lynch S, Ribeiro H, Frostick CJ, Singer LT.
    J Psychopharmacol; 2010 Sep; 24(9):1403-10. PubMed ID: 19939863
    [Abstract] [Full Text] [Related]

  • 30. Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.
    Blagrove M, Seddon J, George S, Parrott AC, Stickgold R, Walker MP, Jones KA, Morgan MJ.
    J Psychopharmacol; 2011 Apr; 25(4):465-77. PubMed ID: 20615932
    [Abstract] [Full Text] [Related]

  • 31. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
    Burgess AP, Venables L, Jones H, Edwards R, Parrott AC.
    Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
    Falck RS, Wang J, Carlson RG.
    J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
    [Abstract] [Full Text] [Related]

  • 34. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Parrott AC, Montgomery C, Wetherell MA, Downey LA, Stough C, Scholey AB.
    Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
    [Abstract] [Full Text] [Related]

  • 37. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences.
    Verheyden SL, Hadfield J, Calin T, Curran HV.
    Psychopharmacology (Berl); 2002 Apr; 161(1):23-31. PubMed ID: 11967627
    [Abstract] [Full Text] [Related]

  • 38. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.
    Brunt TM, Koeter MW, Niesink RJ, van den Brink W.
    Psychopharmacology (Berl); 2012 Apr; 220(4):751-62. PubMed ID: 21993879
    [Abstract] [Full Text] [Related]

  • 39. Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes.
    Parrott AC, Lock J, Conner AC, Kissling C, Thome J.
    Neuropsychobiology; 2008 Apr; 57(4):165-80. PubMed ID: 18654086
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.